Brain Health in Midlife
Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Oct 11, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Participated in the ADORE trial ( R01 HD083292)
- Exclusion Criteria:
- • History of seizures or Epilepsy
- • Pregnant at screening
- • Ineligible to complete MRI due to metal in the body
About University Of Kansas Medical Center
The University of Kansas Medical Center (KUMC) is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical practice. As a prominent clinical trial sponsor, KUMC leverages its extensive expertise in diverse medical fields to conduct rigorous clinical research aimed at improving patient outcomes and developing new treatment modalities. With a commitment to ethical standards and patient safety, KUMC collaborates with multidisciplinary teams to facilitate groundbreaking studies that address significant health challenges, ultimately contributing to the advancement of medical knowledge and the enhancement of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kansas City, Kansas, United States
Patients applied
Trial Officials
Holly R Hull, PhD
Principal Investigator
The University of Kansas Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported